TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2071475
log Bayes Factor = 70.4607
Chromosome 6   position 32,782,387  (GRCh37) Explore rs2071475 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.999 0.001 0.000
I25 Chronic ischaemic heart disease
0.998 0.002 0.000
E10.1 With ketoacidosis
0.000 0.005 0.995
I20-I25 Ischaemic heart diseases
0.995 0.005 0.000
I25.8 Other forms of chronic ischaemic heart disease
0.989 0.011 0.000
I25.9 Chronic ischaemic heart disease, unspecified
0.989 0.011 0.000
I21 Acute myocardial infarction
0.988 0.012 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.986 0.014 0.000
E10.3 With ophthalmic complications
0.000 0.018 0.982
I21.9 Acute myocardial infarction, unspecified
0.982 0.018 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.949 0.051 0.000
T42.4 Benzodiazepines
0.948 0.052 0.000
I24 Other acute ischaemic heart diseases
0.940 0.060 0.000
E10.4 With neurological complications
0.000 0.065 0.935
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.932 0.068 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.930 0.070 0.000
I25.1 Atherosclerotic heart disease
0.929 0.071 0.000
C82.0 Small cleaved cell, follicular
0.928 0.072 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.923 0.077 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.916 0.084 0.000
I24.9 Acute ischaemic heart disease, unspecified
0.914 0.086 0.000
I25.3 Aneurysm of heart
0.914 0.086 0.000
D86 Sarcoidosis
0.000 0.089 0.911
D86.9 Sarcoidosis, unspecified
0.000 0.090 0.910
I21.2 Acute transmural myocardial infarction of other sites
0.891 0.109 0.000
E10.2 With renal complications
0.000 0.110 0.890
D80-D89 Certain disorders involving the immune mechanism
0.000 0.110 0.890
D50-D53 Nutritional anaemias
0.000 0.111 0.889
D51 Vitamin B12 deficiency anaemia
0.000 0.112 0.888
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency
0.000 0.113 0.887
D86.0 Sarcoidosis of lung
0.000 0.114 0.886
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.000 0.119 0.881
E10.8 With unspecified complications
0.000 0.127 0.873
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.867 0.133 0.000
I23 Certain current complications following acute myocardial infarction
0.864 0.136 0.000
C82.2 Large cell, follicular
0.862 0.138 0.000
E10.0 With coma
0.000 0.150 0.850
L40.1 Generalised pustular psoriasis
0.844 0.156 0.000
I25.2 Old myocardial infarction
0.838 0.162 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.832 0.168 0.000
C82.3 Follicular lymphoma grade IIIa
0.824 0.176 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.000 0.189 0.811
D52 Folate deficiency anaemia
0.000 0.190 0.810
I21.1 Acute transmural myocardial infarction of inferior wall
0.800 0.200 0.000
I22 Subsequent myocardial infarction
0.796 0.204 0.000
D86.8 Sarcoidosis of other and combined sites
0.000 0.208 0.792
C82.4 Follicular lymphoma grade IIIb
0.791 0.208 0.000
L40.4 Guttate psoriasis
0.790 0.210 0.000
D50 Iron deficiency anaemia
0.000 0.213 0.787
T43.2 Other and unspecified antidepressants
0.773 0.227 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.769 0.231 0.000
D50.9 Iron deficiency anaemia, unspecified
0.000 0.233 0.767
L40.0 Psoriasis vulgaris
0.766 0.234 0.000
C44 Other malignant neoplasms of skin
0.765 0.235 0.000
D69 Purpura and other haemorrhagic conditions
0.000 0.241 0.759
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.000 0.244 0.756
C44.7 Skin of lower limb, including hip
0.755 0.245 0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.753 0.247 0.000
D52.9 Folate deficiency anaemia, unspecified
0.000 0.247 0.753
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.752 0.248 0.000
I21.4 Acute subendocardial myocardial infarction
0.752 0.248 0.000
C44.2 Skin of ear and external auricular canal
0.751 0.249 0.000
E10.6 With other specified complications
0.000 0.250 0.750
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.749 0.251 0.000
C44.4 Skin of scalp and neck
0.749 0.251 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.745 0.255 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.742 0.258 0.000
I24.8 Other forms of acute ischaemic heart disease
0.741 0.259 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.740 0.260 0.000
C44.3 Skin of other and unspecified parts of face
0.739 0.261 0.000
T42.0 Hydantoin derivatives
0.732 0.267 0.000
M07.3 Other psoriatic arthropathies
0.732 0.268 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.732 0.268 0.000
L40.8 Other psoriasis
0.732 0.268 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.725 0.275 0.000
D69.6 Thrombocytopenia, unspecified
0.000 0.280 0.720
E10.7 With multiple complications
0.000 0.283 0.717
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
I25.6 Silent myocardial ischaemia
0.715 0.284 0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified
0.000 0.287 0.713
M07.30 Other psoriatic arthropathies (Multiple sites)
0.713 0.287 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.709 0.291 0.000
I25.0 Atherosclerotic cardiovascular disease, so described
0.708 0.291 0.000
I21.X Presumed acute myicardial infaction (unconfirmed)
0.708 0.292 0.000
C82.6 Cutaneous follicle centre lymphoma
0.707 0.293 0.000
C82.5 Diffuse follicle centre lymphoma
0.707 0.293 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.703 0.297 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.695 0.304 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.681 0.319 0.000
T42.3 Barbiturates
0.681 0.319 0.000
T42.2 Succinimides and oxazolidinediones
0.681 0.319 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.672 0.328 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.667 0.333 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.667 0.333 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.667 0.333 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.667 0.333 0.000
D89.2 Hypergammaglobulinaemia, unspecified
0.000 0.335 0.665
T50.8 Diagnostic agents
0.662 0.338 0.000
T50.7 Analeptics and opioid receptor antagonists
0.662 0.338 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.662 0.338 0.000
T50.5 Appetite depressants
0.662 0.338 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.662 0.338 0.000
T50.1 Loop [high-ceiling] diuretics
0.662 0.338 0.000
T50.0 Mineralocorticoids and their antagonists
0.662 0.338 0.000
I23.8 Other current complications following acute myocardial infarction
0.659 0.341 0.000
T50.4 Drugs affecting uric acid metabolism
0.659 0.341 0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.000 0.347 0.653
T42.1 Iminostilbenes
0.653 0.347 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.641 0.359 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.000 0.360 0.640
I25.5 Ischaemic cardiomyopathy
0.640 0.360 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.638 0.362 0.000
D81 Combined immunodeficiencies
0.000 0.362 0.638
D51.8 Other vitamin B12 deficiency anaemias
0.000 0.363 0.637
D51.3 Other dietary vitamin B12 deficiency anaemia
0.000 0.363 0.637
D51.2 Transcobalamin II deficiency
0.000 0.363 0.637
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria
0.000 0.363 0.637
I22.0 Subsequent myocardial infarction of anterior wall
0.637 0.363 0.000
T36 Poisoning by systemic antibiotics
0.636 0.364 0.000
D86.1 Sarcoidosis of lymph nodes
0.000 0.365 0.634
T45.0 Antiallergic and antiemetic drugs
0.633 0.367 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.624 0.376 0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.620 0.380 0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.620 0.380 0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.620 0.380 0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.620 0.380 0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.620 0.380 0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.620 0.380 0.000
T38.1 Thyroid hormones and substitutes
0.617 0.383 0.000
D86.3 Sarcoidosis of skin
0.000 0.391 0.609
T47.1 Other antacids and anti-gastric-secretion drugs
0.605 0.395 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.603 0.397 0.000
C44.5 Skin of trunk
0.602 0.398 0.000
D53 Other nutritional anaemias
0.000 0.401 0.598
T43.9 Psychotropic drug, unspecified
0.596 0.403 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.596 0.403 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.596 0.403 0.000
D69.5 Secondary thrombocytopenia
0.000 0.405 0.595
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.594 0.405 0.000
D82 Immunodeficiency associated with other major defects
0.000 0.407 0.593
T45.5 Anticoagulants
0.591 0.409 0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.587 0.413 0.000
D69.0 Allergic purpura
0.000 0.414 0.586
D83 Common variable immunodeficiency
0.000 0.415 0.585
M07.34 Other psoriatic arthropathies (Hand)
0.584 0.416 0.000
D69.4 Other primary thrombocytopenia
0.000 0.417 0.583
D67 Hereditary factor IX deficiency
0.000 0.418 0.582
D52.8 Other folate deficiency anaemias
0.000 0.419 0.580
D52.1 Drug-induced folate deficiency anaemia
0.000 0.419 0.580
D52.0 Dietary folate deficiency anaemia
0.000 0.419 0.580
C44.9 Malignant neoplasm of skin, unspecified
0.571 0.428 0.000
E10.5 With peripheral circulatory complications
0.000 0.428 0.571
I25.4 Coronary artery aneurysm
0.567 0.432 0.000
D50.1 Sideropenic dysphagia
0.000 0.436 0.564
D68 Other coagulation defects
0.000 0.436 0.564
D89.1 Cryoglobulinaemia
0.000 0.436 0.563
D89.9 Disorder involving the immune mechanism, unspecified
0.000 0.441 0.559
I20 Angina pectoris
0.558 0.442 0.000
L40-L45 Papulosquamous disorders
0.558 0.442 0.000
T38.9 Other and unspecified hormone antagonists
0.551 0.449 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.551 0.449 0.000
T38.7 Androgens and anabolic congeners
0.551 0.449 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.551 0.449 0.000
T38.5 Other oestrogens and progestogens
0.551 0.449 0.000
T38.4 Oral contraceptives
0.551 0.449 0.000
T38.2 Antithyroid drugs
0.551 0.449 0.000
T38.0 Glucocorticoids and synthetic analogues
0.551 0.449 0.000
C44.8 Overlapping lesion of skin
0.549 0.451 0.000
C44.0 Skin of lip
0.548 0.452 0.000
D84 Other immunodeficiencies
0.000 0.453 0.547
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.546 0.454 0.000
D69.8 Other specified haemorrhagic conditions
0.000 0.456 0.544
T43.4 Butyrophenone and thioxanthene neuroleptics
0.544 0.456 0.000
K90 Intestinal malabsorption
0.000 0.458 0.542
D69.3 Idiopathic thrombocytopenic purpura
0.000 0.458 0.542
D89.3 Immune reconstitution syndrome
0.000 0.458 0.542
D89.0 Polyclonal hypergammaglobulinaemia
0.000 0.458 0.542
T45.9 Primarily systemic and haematological agent, unspecified
0.539 0.461 0.000
T45.8 Other primarily systemic and haematological agents
0.539 0.461 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.539 0.461 0.000
T45.6 Fibrinolysis-affecting drugs
0.539 0.461 0.000
T45.4 Iron and its compounds
0.539 0.461 0.000
T45.3 Enzymes, not elsewhere classified
0.539 0.461 0.000
D66 Hereditary factor VIII deficiency
0.000 0.461 0.539
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.538 0.462 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.531 0.469 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.531 0.469 0.000
T47.7 Emetics
0.531 0.469 0.000
T47.6 Antidiarrhoeal drugs
0.531 0.469 0.000
T47.5 Digestants
0.531 0.469 0.000
T47.4 Other laxatives
0.531 0.469 0.000
T47.3 Saline and osmotic laxatives
0.531 0.469 0.000
T47.2 Stimulant laxatives
0.531 0.469 0.000
T47.0 Histamine H(2)-receptor antagonists
0.531 0.469 0.000
I24.1 Dressler's syndrome
0.528 0.472 0.000
D69.9 Haemorrhagic condition, unspecified
0.000 0.474 0.526
M07.38 Other psoriatic arthropathies (Other)
0.525 0.475 0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.525 0.475 0.000
M07.33 Other psoriatic arthropathies (Forearm)
0.525 0.475 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.525 0.475 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.525 0.475 0.000
T45.2 Vitamins, not elsewhere classified
0.523 0.477 0.000
D55-D59 Haemolytic anaemias
0.000 0.482 0.518
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.511 0.489 0.000
D68.8 Other specified coagulation defects
0.000 0.495 0.505
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.504 0.496 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.504 0.496 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.504 0.496 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.504 0.496 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.504 0.496 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.504 0.496 0.000
T44.0 Anticholinesterase agents
0.504 0.496 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.502 0.498 0.000
T43.6 Psychostimulants with abuse potential
0.499 0.501 0.000
D69.2 Other nonthrombocytopenic purpura
0.000 0.505 0.495
I22.8 Subsequent myocardial infarction of other sites
0.489 0.511 0.000
D80 Immunodeficiency with predominantly antibody defects
0.000 0.515 0.485
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.000 0.518 0.482
I20.1 Angina pectoris with documented spasm
0.482 0.518 0.000
D68.0 Von Willebrand's disease
0.000 0.520 0.480
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.478 0.522 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.478 0.522 0.000
T37.5 Antiviral drugs
0.478 0.522 0.000
T37.4 Anthelminthics
0.478 0.522 0.000
T37.3 Other antiprotozoal drugs
0.478 0.522 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.478 0.522 0.000
T37.1 Antimycobacterial drugs
0.478 0.522 0.000
T37.0 Sulphonamides
0.478 0.522 0.000
T41.5 Therapeutic gases
0.478 0.522 0.000
T41.4 Anaesthetic, unspecified
0.478 0.522 0.000
T41.3 Local anaesthetics
0.478 0.522 0.000
T41.2 Other and unspecified general anaesthetics
0.478 0.522 0.000
T41.1 Intravenous anaesthetics
0.478 0.522 0.000
T41.0 Inhaled anaesthetics
0.478 0.522 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.478 0.522 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.478 0.522 0.000
T48.5 Anti-common-cold drugs
0.478 0.522 0.000
T48.4 Expectorants
0.478 0.522 0.000
T48.3 Antitussives
0.478 0.522 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.478 0.522 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.478 0.522 0.000
T48.0 Oxytocic drugs
0.478 0.522 0.000
T49.9 Topical agent, unspecified
0.478 0.522 0.000
T49.8 Other topical agents
0.478 0.522 0.000
T49.7 Dental drugs, topically applied
0.478 0.522 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.478 0.522 0.000
T49.5 Ophthalmological drugs and preparations
0.478 0.522 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.478 0.522 0.000
T49.3 Emollients, demulcents and protectants
0.478 0.522 0.000
T49.2 Local astringents and local detergents
0.478 0.522 0.000
T49.1 Antipruritics
0.478 0.522 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.478 0.522 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.474 0.526 0.000
L42 Pityriasis rosea
0.458 0.542 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.458 0.542 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.458 0.542 0.000
T46.7 Peripheral vasodilators
0.458 0.542 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.458 0.542 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.458 0.542 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.458 0.542 0.000
D81.9 Combined immunodeficiency, unspecified
0.000 0.542 0.457
D81.8 Other combined immunodeficiencies
0.000 0.542 0.457
D81.7 Major histocompatibility complex class II deficiency
0.000 0.542 0.457
D81.6 Major histocompatibility complex class I deficiency
0.000 0.542 0.457
D81.5 Purine nucleoside phosphorylase [PNP] deficiency
0.000 0.542 0.457
D81.4 Nezelof's syndrome
0.000 0.542 0.457
D81.3 Adenosine deaminase [ADA] deficiency
0.000 0.542 0.457
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
0.000 0.542 0.457
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
0.000 0.542 0.457
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis
0.000 0.542 0.457
C44.1 Skin of eyelid, including canthus
0.457 0.543 0.000
T36.9 Systemic antibiotic, unspecified
0.456 0.544 0.000
T36.8 Other systemic antibiotics
0.456 0.544 0.000
T36.7 Antifungal antibiotics, systemically used
0.456 0.544 0.000
T36.6 Rifamycins
0.456 0.544 0.000
T36.5 Aminoglycosides
0.456 0.544 0.000
T36.4 Tetracyclines
0.456 0.544 0.000
T36.3 Macrolides
0.456 0.544 0.000
T36.2 Chloramphenicol group
0.456 0.544 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.456 0.544 0.000
D69.1 Qualitative platelet defects
0.000 0.550 0.449
K90.9 Intestinal malabsorption, unspecified
0.000 0.558 0.442
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.440 0.559 0.000
T46.1 Calcium-channel blockers
0.438 0.561 0.000
D68.5 Primary Thrombophilia
0.000 0.569 0.431
D53.8 Other specified nutritional anaemias
0.000 0.571 0.429
D53.2 Scorbutic anaemia
0.000 0.571 0.429
D53.1 Other megaloblastic anaemias, not elsewhere classified
0.000 0.571 0.429
D53.0 Protein deficiency anaemia
0.000 0.571 0.429
T36.0 Penicillins
0.426 0.574 0.000
D82.9 Immunodeficiency associated with major defect, unspecified
0.000 0.575 0.425
D82.8 Immunodeficiency associated with other specified major defects
0.000 0.575 0.425
D82.4 Hyperimmunoglobulin E [IgE] syndrome
0.000 0.575 0.425
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus
0.000 0.575 0.425
D82.2 Immunodeficiency with short-limbed stature
0.000 0.575 0.425
D82.0 Wiskott-Aldrich syndrome
0.000 0.575 0.425
T43.0 Tricyclic and tetracyclic antidepressants
0.422 0.578 0.000
D83.8 Other common variable immunodeficiencies
0.000 0.581 0.419
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells
0.000 0.581 0.419
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
0.000 0.581 0.419
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
0.000 0.581 0.419
I22.9 Subsequent myocardial infarction of unspecified site
0.419 0.581 0.000
D50.8 Other iron deficiency anaemias
0.000 0.583 0.417
C43-C44 Melanoma and other malignant neoplasms of skin
0.416 0.584 0.000
D68.9 Coagulation defect, unspecified
0.000 0.587 0.413
K90.8 Other intestinal malabsorption
0.000 0.588 0.412
D59 Acquired haemolytic anaemia
0.000 0.600 0.400
L44 Other papulosquamous disorders
0.400 0.600 0.000
L41 Parapsoriasis
0.400 0.600 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.400 0.600 0.000
L43 Lichen planus
0.399 0.601 0.000
D84.8 Other specified immunodeficiencies
0.000 0.607 0.392
D84.1 Defects in the complement system
0.000 0.607 0.392
D84.0 Lymphocyte function antigen-1 [LFA-1] defect
0.000 0.607 0.392
D53.9 Nutritional anaemia, unspecified
0.000 0.610 0.390
D68.6 Other Thrombophilia
0.000 0.611 0.389
K90.3 Pancreatic steatorrhoea
0.000 0.611 0.389
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.611 0.389
K90.1 Tropical sprue
0.000 0.611 0.389
T46.5 Other antihypertensive drugs, not elsewhere classified
0.384 0.615 0.000
D82.1 Di George's syndrome
0.000 0.620 0.380
T46.4 Angiotensin-converting-enzyme inhibitors
0.375 0.625 0.000
D68.1 Hereditary factor XI deficiency
0.000 0.626 0.374
J45.9 Asthma, unspecified
0.000 0.626 0.374
D57 Sickle-cell disorders
0.000 0.629 0.371
D55 Anaemia due to enzyme disorders
0.000 0.629 0.371
D83.9 Common variable immunodeficiency, unspecified
0.000 0.634 0.366
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.635 0.365
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.361 0.638 0.001
D59.1 Other autoimmune haemolytic anaemias
0.000 0.648 0.352
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.000 0.652 0.348
D80.8 Other immunodeficiencies with predominantly antibody defects
0.000 0.652 0.348
D80.7 Transient hypogammaglobulinaemia of infancy
0.000 0.652 0.348
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.000 0.652 0.348
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.000 0.652 0.348
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.000 0.652 0.348
D80.0 Hereditary hypogammaglobulinaemia
0.000 0.652 0.348
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.336 0.664 0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.000 0.666 0.334
I20.9 Angina pectoris, unspecified
0.332 0.668 0.000
M07 Psoriatic and enteropathic arthropathies
0.330 0.670 0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]
0.000 0.673 0.326
I20.0 Unstable angina
0.325 0.675 0.000
D68.4 Acquired coagulation factor deficiency
0.000 0.684 0.316
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.316 0.684 0.000
T40.8 Lysergide [LSD]
0.316 0.684 0.000
T40.7 Cannabis (derivatives)
0.316 0.684 0.000
T40.5 Cocaine
0.316 0.684 0.000
T40.3 Methadone
0.316 0.684 0.000
T40.1 Heroin
0.316 0.684 0.000
T40.0 Opium
0.316 0.684 0.000
L43.9 Lichen planus, unspecified
0.311 0.689 0.000
C85.1 B-cell lymphoma, unspecified
0.308 0.692 0.000
D58 Other hereditary haemolytic anaemias
0.000 0.693 0.307
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)
0.000 0.694 0.306
T40.6 Other and unspecified narcotics
0.304 0.696 0.000
D84.9 Immunodeficiency, unspecified
0.001 0.698 0.301
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.000 0.703 0.297
D56 Thalassaemia
0.001 0.707 0.292
Chapter II Neoplasms
0.290 0.710 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.290 0.710 0.000
D59.8 Other acquired haemolytic anaemias
0.000 0.713 0.287
D59.6 Haemoglobinuria due to haemolysis from other external causes
0.000 0.713 0.287
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
0.000 0.713 0.287
D59.4 Other nonautoimmune haemolytic anaemias
0.000 0.713 0.287
D59.3 Haemolytic-uraemic syndrome
0.000 0.713 0.287
D59.2 Drug-induced nonautoimmune haemolytic anaemia
0.000 0.713 0.287
L41.9 Parapsoriasis, unspecified
0.287 0.713 0.000
L41.8 Other parapsoriasis
0.287 0.713 0.000
L41.5 Retiform parapsoriasis
0.287 0.713 0.000
L41.4 Large plaque parapsoriasis
0.287 0.713 0.000
L41.3 Small plaque parapsoriasis
0.287 0.713 0.000
L41.2 Lymphomatoid papulosis
0.287 0.713 0.000
L41.1 Pityriasis lichenoides chronica
0.287 0.713 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.287 0.713 0.000
L44.9 Papulosquamous disorder, unspecified
0.287 0.713 0.000
L44.8 Other specified papulosquamous disorders
0.287 0.713 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.287 0.713 0.000
L44.3 Lichen ruber moniliformis
0.287 0.713 0.000
L44.2 Lichen striatus
0.287 0.713 0.000
L44.1 Lichen nitidus
0.287 0.713 0.000
L44.0 Pityriasis rubra pilaris
0.287 0.713 0.000
L43.3 Subacute (active) lichen planus
0.286 0.714 0.000
L43.2 Lichenoid drug reaction
0.286 0.714 0.000
L43.1 Bullous lichen planus
0.286 0.714 0.000
L43.0 Hypertrophic lichen planus
0.286 0.714 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.285 0.715 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.284 0.716 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.279 0.721 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.276 0.724 0.000
D60-D64 Aplastic and other anaemias
0.000 0.727 0.273
C95 Leukaemia of unspecified cell type
0.270 0.730 0.001
C02 Malignant neoplasm of other and unspecified parts of tongue
0.270 0.730 0.000
T40.2 Other opioids
0.267 0.733 0.000
D55.9 Anaemia due to enzyme disorder, unspecified
0.000 0.733 0.266
D55.8 Other anaemias due to enzyme disorders
0.000 0.733 0.266
D55.3 Anaemia due to disorders of nucleotide metabolism
0.000 0.733 0.266
D55.2 Anaemia due to disorders of glycolytic enzymes
0.000 0.733 0.266
D55.1 Anaemia due to other disorders of glutathione metabolism
0.000 0.733 0.266
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
0.000 0.733 0.266
D57.8 Other sickle-cell disorders
0.000 0.733 0.266
D57.3 Sickle-cell trait
0.000 0.733 0.266
D57.2 Double heterozygous sickling disorders
0.000 0.733 0.266
D57.1 Sickle-cell anaemia without crisis
0.000 0.733 0.266
D57.0 Sickle-cell anaemia with crisis
0.000 0.733 0.266
C86 Other specified types of T/NK-cell lymphoma
0.262 0.738 0.001
C73 Malignant neoplasm of thyroid gland
0.262 0.738 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.259 0.740 0.001
C94 Other leukaemias of specified cell type
0.259 0.740 0.001
D80.1 Nonfamilial hypogammaglobulinaemia
0.000 0.742 0.257
D59.0 Drug-induced autoimmune haemolytic anaemia
0.000 0.743 0.257
L43.8 Other lichen planus
0.254 0.746 0.000
I20.8 Other forms of angina pectoris
0.252 0.748 0.000
C93 Monocytic leukaemia
0.250 0.749 0.001
C02.1 Border of tongue
0.246 0.754 0.000
D59.9 Acquired haemolytic anaemia, unspecified
0.000 0.756 0.244
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.241 0.759 0.000
C85.0 Lymphosarcoma
0.241 0.759 0.000
C02.9 Tongue, unspecified
0.237 0.763 0.000
C74 Malignant neoplasm of adrenal gland
0.237 0.763 0.000
M07.6 Other enteropathic arthropathies
0.237 0.763 0.000
M07.5 Arthropathy in ulcerative colitis
0.237 0.763 0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.237 0.763 0.000
M07.2 Psoriatic spondylitis
0.237 0.763 0.000
M07.1 Arthritis mutilans
0.237 0.763 0.000
M07.0 Distal interphalangeal psoriatic arthropathy
0.237 0.763 0.000
C90.0 Multiple myeloma
0.229 0.771 0.000
C12 Malignant neoplasm of pyriform sinus
0.229 0.771 0.000
D00-D09 In situ neoplasms
0.228 0.772 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.226 0.774 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.225 0.774 0.000
D68.2 Hereditary deficiency of other clotting factors
0.000 0.775 0.225
D04 Carcinoma in situ of skin
0.224 0.776 0.000
C11 Malignant neoplasm of nasopharynx
0.223 0.777 0.000
C03 Malignant neoplasm of gum
0.221 0.779 0.000
D58.8 Other specified hereditary haemolytic anaemias
0.000 0.779 0.220
D58.1 Hereditary elliptocytosis
0.000 0.779 0.220
C84 Peripheral and cutaneous T-cell lymphomas
0.219 0.780 0.001
C06 Malignant neoplasm of other and unspecified parts of mouth
0.220 0.780 0.000
C02.4 Lingual tonsil
0.218 0.782 0.000
C88 Malignant immunoproliferative diseases
0.210 0.789 0.001
C02.2 Ventral surface of tongue
0.211 0.789 0.000
D56.9 Thalassaemia, unspecified
0.001 0.790 0.210
D56.8 Other thalassaemias
0.001 0.790 0.210
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]
0.001 0.790 0.210
D56.2 Delta-beta thalassaemia
0.001 0.790 0.210
D56.0 Alpha thalassaemia
0.001 0.790 0.210
T40.4 Other synthetic narcotics
0.210 0.790 0.000
C13 Malignant neoplasm of hypopharynx
0.210 0.790 0.000
T39.4 Antirheumatics, not elsewhere classified
0.208 0.792 0.000
T39.2 Pyrazolone derivatives
0.208 0.792 0.000
C90.2 Plasmacytoma, extramedullary
0.206 0.794 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.205 0.794 0.000
C90.1 Plasma cell leukaemia
0.204 0.795 0.000
C90.3 Solitary plasmacytoma
0.204 0.795 0.000
C95.9 Leukaemia, unspecified
0.204 0.795 0.000
D04.3 Skin of other and unspecified parts of face
0.204 0.796 0.000
D58.0 Hereditary spherocytosis
0.000 0.796 0.204
D58.2 Other haemoglobinopathies
0.000 0.797 0.203
D58.9 Hereditary haemolytic anaemia, unspecified
0.000 0.799 0.201
T39.1 4-Aminophenol derivatives
0.201 0.799 0.000
C05 Malignant neoplasm of palate
0.200 0.800 0.000
D04.4 Skin of scalp and neck
0.196 0.804 0.000
J45 Asthma
0.000 0.804 0.196
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.000 0.804 0.196
C95.7 Other leukaemia of unspecified cell type
0.193 0.806 0.001
C95.2 Subacute leukaemia of unspecified cell type
0.193 0.806 0.001
C95.1 Chronic leukaemia of unspecified cell type
0.193 0.806 0.001
C95.0 Acute leukaemia of unspecified cell type
0.193 0.806 0.001
D63 Anaemia in chronic diseases classified elsewhere
0.000 0.806 0.194
C02.8 Overlapping lesion of tongue
0.194 0.806 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.194 0.806 0.000
C02.0 Dorsal surface of tongue
0.194 0.806 0.000
D04.5 Skin of trunk
0.193 0.807 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.193 0.807 0.000
C00 Malignant neoplasm of lip
0.193 0.807 0.000
C74.0 Cortex of adrenal gland
0.193 0.807 0.000
C74.9 Adrenal gland, unspecified
0.192 0.808 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.191 0.809 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.191 0.809 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.190 0.809 0.001
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.190 0.810 0.000
C04 Malignant neoplasm of floor of mouth
0.190 0.810 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.190 0.810 0.000
C91 Lymphoid leukaemia
0.187 0.812 0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.188 0.812 0.001
C86.4 Blastic NK-cell lymphoma
0.188 0.812 0.001
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.188 0.812 0.001
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.188 0.812 0.001
C86.1 Hepatosplenic T-cell lymphoma
0.188 0.812 0.001
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.188 0.812 0.001
D56.3 Thalassaemia trait
0.001 0.812 0.187
C94.7 Other specified leukaemias
0.186 0.813 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.